FDA Approves Ustekinumab Biosimilar Otulfi

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

This is the fourth ustekinumab biosimilar approval in the United States, with the drug set to launch in 2025.
Medscape Medical News